These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1562029)
21. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy. Chen HH; Hsu MT; Wu CJ; Chen YW; Yang TL Am J Surg; 2008 Aug; 196(2):155-9. PubMed ID: 18513687 [TBL] [Abstract][Full Text] [Related]
22. Ultrasonically guided chemical parathyroidectomy in patients with primary hyperparathyroidism: a follow-up study. Karstrup S; Hegedüs L; Holm HH Clin Endocrinol (Oxf); 1993 May; 38(5):523-30. PubMed ID: 8330447 [TBL] [Abstract][Full Text] [Related]
23. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917 [TBL] [Abstract][Full Text] [Related]
25. Hyperparathyroidism caused by distant pulmonary lesions and parathyromatosis after ethanol injection/parathyroidectomy for secondary hyperparathyroidism. Nakamura M; Tanaka K; Fujii T Hemodial Int; 2017 Jul; 21(3):E45-E49. PubMed ID: 28078796 [TBL] [Abstract][Full Text] [Related]
26. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism. Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800 [TBL] [Abstract][Full Text] [Related]
27. Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism. Fang L; Tang B; Hou D; Meng M; Xiong M; Yang J BMC Nephrol; 2015 Jun; 16():82. PubMed ID: 26058796 [TBL] [Abstract][Full Text] [Related]
28. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Solbiati L; Giangrande A; De Pra L; Bellotti E; Cantù P; Ravetto C Radiology; 1985 Jun; 155(3):607-10. PubMed ID: 3889999 [TBL] [Abstract][Full Text] [Related]
29. Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients. Onoda N; Kashiwagi T; Nakamura T; Niitsu Y; Omata M; Kurihara S Ther Apher Dial; 2005 Aug; 9 Suppl 1():S11-5. PubMed ID: 16109135 [TBL] [Abstract][Full Text] [Related]
30. Intraoperative measurement of intact parathyroid hormone in renal hyperparathyroidism by an inexpensive routine assay. Seehofer D; Rayes N; Ulrich F; Müller C; Lang M; Neuhaus P; Steinmüller T Langenbecks Arch Surg; 2001 Nov; 386(6):440-3. PubMed ID: 11735018 [TBL] [Abstract][Full Text] [Related]
31. Parathyroid graft function after presternal subcutaneous autotransplantation for renal hyperparathyroidism. Echenique-Elizondo M; Díaz-Aguirregoitia FJ; Amondarain JA; Vidaur F Arch Surg; 2006 Jan; 141(1):33-8. PubMed ID: 16415409 [TBL] [Abstract][Full Text] [Related]
32. Rapid recurrence of hyperparathyroidism from both nodularly hyperplastic autograft at forearm and residual tissues at neck after parathyroidectomy in a hemodialysis patient with calciphylaxis. Yeh CT; Lin YP; Yang WC; Yang AH; Lai MY; Lin CC Am J Med Sci; 2006 May; 331(5):284-7. PubMed ID: 16702801 [TBL] [Abstract][Full Text] [Related]
33. Ultrasound-guided percutaneous ethanol ablation of parathyroid hyperplasia: preliminary experience in patients on chronic dialysis. Schamp S; Dünser E; Schuster H; Kramer-Deimer J; Kettenbach J; Funovics M; Lang U; Meisl FT; Umek H Ultraschall Med; 2004 Apr; 25(2):131-6. PubMed ID: 15085455 [TBL] [Abstract][Full Text] [Related]
35. Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism. Nakamura M; Fuchinoue S; Teraoka S Am J Kidney Dis; 2003 Oct; 42(4):739-45. PubMed ID: 14520624 [TBL] [Abstract][Full Text] [Related]
36. [Effect of calcitriol on secondary hyperparathyroidism]. Xu H; Zhang J; Cheng X; Zhou Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):920-4. PubMed ID: 24071691 [TBL] [Abstract][Full Text] [Related]
37. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism. Albuquerque RFC; Carbonara CEM; Martin RCT; Dos Reis LM; do Nascimento CP; Arap SS; Moysés RMA; Jorgetti V; Montenegro FLM; de Oliveira RB Surgery; 2018 Feb; 163(2):381-387. PubMed ID: 29146232 [TBL] [Abstract][Full Text] [Related]
38. Acute change in parathyroid function in primary hyperparathyroidism following ultrasonically guided ethanol injection into solitary parathyroid adenomas. Karstrup S; Hegedüs L; Holm HH Acta Endocrinol (Copenh); 1993 Nov; 129(5):377-80. PubMed ID: 8279217 [TBL] [Abstract][Full Text] [Related]
39. [Surgical treatment of secondary hyperparathyroidism (The first experience in Klaipeda region)]. Kasiliauskiene A; Priluckiene J; Slepavicius A Medicina (Kaunas); 2005; 41 Suppl 1():50-4. PubMed ID: 15901976 [TBL] [Abstract][Full Text] [Related]
40. Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland. Yumita S Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii62-4. PubMed ID: 12771304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]